This article is a retraction of:
RETRACTED: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling
Frontiers Editorial Office*A Retraction of the Original Research Article
RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling
by Luo C, Zhu X, Luo Q, Bu F, Huang C, Zhu J, Zhao J, Zhang W, Lin K, Hu C, Zong Z, Luo H, Huang J and Zhu Z (2020). Front. Oncol. 10:1044. doi: 10.3389/fonc.2020.01044
The journal retracts the 20 July 2020 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors did not agree to this retraction.
Citation: Frontiers Editorial Office (2021) Retraction: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling. Front. Oncol. 11:738970. doi: 10.3389/fonc.2021.738970
Received: 09 July 2021; Accepted: 12 July 2021;
Published: 31 August 2021.
Approved by:
Giuseppe Giaccone, Cornell University, United StatesCopyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org